Search

everythinglearnresearchcommunity

for

Search:↓

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Finasteride may effectively reduce Tourette's syndrome symptoms and improve life quality.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

Tofacitinib may effectively treat folliculitis decalvans.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.